These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31989657)

  • 41. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
    Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
    J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of benign prostatic hyperplasia with Croton membranaceus in an experimental animal model.
    Afriyie DK; Asare GA; Bugyei K; Adjei S; Lin JM; Peng J; Hong ZF
    J Ethnopharmacol; 2014 Nov; 157():90-8. PubMed ID: 25256687
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Chung EH; Kim JW; Kim JH; Jeong JS; Lim JH; Boo SY; Ko JW; Kim TW
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064710
    [No Abstract]   [Full Text] [Related]  

  • 44. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostatotropic Action of Glycyrrhizic Acid Disodium Salt in Benign Prostatic Hyperplasia Models.
    Nizomov SA; Sorokina IV; Zhukova NA; Borisov SA; Tolstikova TG; Semenov DE; Bakarev MA
    Bull Exp Biol Med; 2020 May; 169(1):114-118. PubMed ID: 32488776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative.
    Yang X; Yuan L; Xiong C; Yin C; Ruan J
    J Ethnopharmacol; 2014 Nov; 157():105-13. PubMed ID: 25260581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Yohimbine hydrochloride inhibits benign prostatic hyperplasia by downregulating steroid 5α-reductase type 2.
    Zhao Y; Zhang Y; Li Y; Yang M; Yuan J; Cao Y; Xu L; Ma X; Lin S; An J; Wang S
    Eur J Pharmacol; 2021 Oct; 908():174334. PubMed ID: 34265299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological effects of the lipidosterolic extract of Serenoa repens (Permixon) on rat prostate hyperplasia induced by hyperprolactinemia: comparison with finasteride.
    Van Coppenolle F; Le Bourhis X; Carpentier F; Delaby G; Cousse H; Raynaud JP; Dupouy JP; Prevarskaya N
    Prostate; 2000 Apr; 43(1):49-58. PubMed ID: 10725865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and efficacy of a novel Prunus domestica extract (Sitoprin, CR002) on testosterone-induced benign prostatic hyperplasia (BPH) in male Wistar rats.
    Swaroop A; Bagchi M; Kumar P; Preuss HG; Bagchi D
    Toxicol Mech Methods; 2015; 25(9):653-64. PubMed ID: 26337762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Efficacy of Kangshuailing Gao on benign prostatic hyperplasia in rats].
    Li R; Jia DY; Li Z; Xu DR; Luo SY
    Zhonghua Nan Ke Xue; 2018 Aug; 24(8):729-734. PubMed ID: 30173434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemical profiles of the active fraction from Prinsepia utilis Royle leaves and its anti-benign prostatic hyperplasia evaluation in animal models.
    Peng Y; Peng C; Wu Y; Sun C; Li X
    BMC Complement Med Ther; 2021 Oct; 21(1):272. PubMed ID: 34715848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasia.
    Rick FG; Schally AV; Block NL; Halmos G; Perez R; Fernandez JB; Vidaurre I; Szalontay L
    Prostate; 2011 May; 71(7):736-47. PubMed ID: 20945403
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rice Hull Extract Suppresses Benign Prostate Hyperplasia by Decreasing Inflammation and Regulating Cell Proliferation in Rats.
    Kim CY; Chung KS; Cheon SY; Lee JH; Park YB; An HJ
    J Med Food; 2016 Aug; 19(8):746-54. PubMed ID: 27441629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).
    Paterniti I; Campolo M; Cordaro M; Siracusa R; Filippone A; Esposito E; Cuzzocrea S
    Inflamm Res; 2018 Jul; 67(7):617-626. PubMed ID: 29679313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of benign prostatic hyperplasia with 5-alpha-reductase inhibitor: morphological changes in patients who fail to respond.
    Montironi R; Valli M; Fabris G
    J Clin Pathol; 1996 Apr; 49(4):324-8. PubMed ID: 8655710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anthocyanin extracted from black soybean reduces prostate weight and promotes apoptosis in the prostatic hyperplasia-induced rat model.
    Jang H; Ha US; Kim SJ; Yoon BI; Han DS; Yuk SM; Kim SW
    J Agric Food Chem; 2010 Dec; 58(24):12686-91. PubMed ID: 21121678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Veratrum maackii on Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats.
    Park HS; Seo CS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Kwun HJ
    Biol Pharm Bull; 2019 Jan; 42(1):1-9. PubMed ID: 30381617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride.
    Sáez C; González-Baena AC; Japón MA; Giráldez J; Segura DI; Rodríguez-Vallejo JM; González-Esteban J; Miranda G; Torrubia F
    Prostate; 1999 Jul; 40(2):83-8. PubMed ID: 10386468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature.
    Busetto GM; Del Giudice F; D'Agostino D; Romagnoli D; Minervini A; Rocco B; Antonelli A; Celia A; Schiavina R; Cindolo L; Chung BI; Kim JH; Maggi M; Sciarra A; De Berardinis E; Porreca A
    Arch Ital Urol Androl; 2020 Jan; 91(4):205-210. PubMed ID: 31937082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.